The relationship between the physician and pharmaceutical industry: background ethics and regulation proposals.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Connecting for Success: The Role of Networking in Medical Education.Cureus · 2024
   Review
2. Barriers to rational antibiotic prescription in Iran: a descriptive qualitative study.Antimicrobial resistance and infection control · 2022
   Article
3. Interaction between physicians and the pharmaceutical industry: A scoping review for developing a policy brief.Frontiers in public health · 2022
   Article
4. Irrational use of antibiotics in Iran from the perspective of complex adaptive systems: redefining the challenge.BMC public health · 2021
   Article
5. Evaluating Physician Burnout and the Need for Organizational Support.Missouri medicine
   Article
6. Disparities Among Industry's Highly Compensated Orthopaedic Surgeons.JB & JS open access
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.